Seres Therapeutics, Inc. — All Filings
682 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
PRE 14A
PREM14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001950047-26-002749 | Mar 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-108482 | Mar 16, 2026 | — |
| 8-K | 8-K | 0001193125-26-103034 | Mar 12, 2026 | — |
| 10-K | 10-K | 0001193125-26-103276 | Mar 12, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-102617 | Mar 11, 2026 | Mar 4, 2026 |
| 3 | 3 | 0001193125-26-102609 | Mar 11, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-096678 | Mar 6, 2026 | Mar 4, 2026 |
| 4 | 4 | 0001193125-26-096692 | Mar 6, 2026 | Mar 4, 2026 |
| 4 | 4 | 0001193125-26-096711 | Mar 6, 2026 | Mar 4, 2026 |
| 4 | 4 | 0001193125-26-096700 | Mar 6, 2026 | Mar 4, 2026 |
| 8-K | 8-K | 0001193125-26-085368 | Mar 2, 2026 | Feb 27, 2026 |
| 4 | 4 | 0001193125-26-057157 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-26-057154 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-26-057156 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-26-057153 | Feb 18, 2026 | Feb 15, 2026 |
| 4 | 4 | 0001193125-25-286236 | Nov 18, 2025 | Nov 15, 2025 |
| 4 | 4 | 0001193125-25-286226 | Nov 18, 2025 | Nov 15, 2025 |
| 4 | 4 | 0001193125-25-286240 | Nov 18, 2025 | Nov 15, 2025 |
| 4 | 4 | 0001193125-25-286235 | Nov 18, 2025 | Nov 15, 2025 |
| 8-K | 8-K | 0001193125-25-265708 | Nov 5, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-266011 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-230118 | Oct 3, 2025 | Sep 23, 2025 |
| 4 | 4 | 0001193125-25-225103 | Sep 30, 2025 | Sep 26, 2025 |
| 4 | 4 | 0001193125-25-225105 | Sep 30, 2025 | Sep 26, 2025 |
| 4 | 4 | 0000950170-25-110096 | Aug 19, 2025 | Aug 15, 2025 |
| 4 | 4 | 0001193125-25-183434 | Aug 19, 2025 | Aug 15, 2025 |
| 4 | 4 | 0000950170-25-110090 | Aug 19, 2025 | Aug 15, 2025 |
| 4 | 4 | 0001193125-25-183436 | Aug 19, 2025 | Aug 15, 2025 |
| 3 | 3 | 0000950170-25-103986 | Aug 6, 2025 | Aug 5, 2025 |
| 4 | 4 | 0000950170-25-104016 | Aug 6, 2025 | Aug 5, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-002160 | Aug 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-173985 | Aug 6, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-103611 | Aug 6, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001193125-25-162552 | Jul 22, 2025 | Jul 17, 2025 |
| 4 | 4 | 0000950170-25-093273 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093285 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093311 | Jul 2, 2025 | Jul 1, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-001632 | Jun 6, 2025 | — |
| 4 | 4 | 0000950170-25-074328 | May 19, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-074327 | May 19, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-074323 | May 19, 2025 | May 15, 2025 |
| 4 | 4 | 0000950170-25-074325 | May 19, 2025 | May 15, 2025 |
| 8-K | 8-K | 0001193125-25-114430 | May 7, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-065173 | May 7, 2025 | Mar 31, 2025 |
| S-8 | S-8 | 0001193125-25-114886 | May 7, 2025 | — |
| 8-K | 8-K | 0001193125-25-089189 | Apr 22, 2025 | Apr 21, 2025 |
| 8-K | 8-K | 0001193125-25-080185 | Apr 14, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053249 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053250 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053248 | Apr 11, 2025 | Apr 10, 2025 |